Wealth Quarterback’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Wealth Quarterback’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$6K	Buy	41 +1	+3%	+$129	﹤0.01%	578
2021 Q2	$6K	Buy	+40	New	+$5.26K	﹤0.01%	594
2020 Q2	–	Sell	-133	Closed	-$10.3K	–	801
2020 Q1	$10.3K	Sell	133 -119	-47%	-$10.5K	0.01%	465
2019 Q4	$24K	Buy	+252	New	+$21.8K	0.02%	322

Other funds holding XBI

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Wealth Quarterback's XBI Position: Q3 2021 in Review

Wealth Quarterback increased its State Street SPDR S&P Biotech ETF (XBI) stake by 2.5% in Q3 2021, buying an estimated $129 and bringing the position to 41 shares worth $6K. The position accounts for ﹤0.01% of the portfolio, ranked #578.

Wealth Quarterback first reported a position in XBI in Q4 2019 and has held it in 4 quarters since. The position peaked at $24K in Q4 2019. 635 funds tracked by Wall St. Rank hold XBI as of Q3 2021.

Wealth Quarterback held 41 shares of State Street SPDR S&P Biotech ETF worth $6K as of Q3 2021.
Wealth Quarterback bought 1 State Street SPDR S&P Biotech ETF share in Q3 2021, an estimated $129.
State Street SPDR S&P Biotech ETF made up ﹤0.01% of Wealth Quarterback's portfolio in Q3 2021, its #578 holding.
Wealth Quarterback first reported a position in State Street SPDR S&P Biotech ETF in Q4 2019 and has held it in 4 quarters since.
Wealth Quarterback's State Street SPDR S&P Biotech ETF position peaked at $24K in Q4 2019.
635 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2021.

Based on Wealth Quarterback's 13F filing for Q3 2021, filed 17 Nov 2021.